Successful treatment of refractory prurigo nodularis with abrocitinib

被引：2
|
作者：
Sun, Fang [1 ]
Wu, Zhenzhen [1 ]
机构：
[1] Jiangsu Univ, Affiliated AoYang Hosp, Derpartment Dermatol, Zhangjiagang 279 Gangcheng Rd, Zhangjiagang, Jiangsu, Peoples R China
来源：
CLINICAL CASE REPORTS | 2024年 / 12卷 / 03期
关键词：
abrocitinib; itching; JAK inhibitor; prurigo nodularis;
D O I：
10.1002/ccr3.8606
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK-STAT signaling may significantly improve prurigo nodularis. Based on the results, we would like to draw a conclusion that abrocitinib as an inhibitor of Jak is a promising choice for the treatment of prurigo nodularis.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Successful treatment of prurigo nodularis with abrocitinib: A case report
    Li, Pei-Ling
    Ma, Jun
    Hung, Chih-Tsung
    DERMATOLOGICA SINICA, 2024, 42 (04)
  • [2] Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases
    Liang, Jingyao
    Li, Wei
    Liu, Wenyan
    Yu, Yihui
    Ye, Hui
    Zhang, Xibao
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1793 - 1797
  • [3] Successful treatment of refractory prurigo nodularis with baricitinib
    Yin, Mengting
    Wu, Ruimiao
    Chen, Jiaying
    Dou, Xia
    DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [4] Dupilumab: A Safe and Successful Treatment in Refractory Prurigo Nodularis
    Cunha, Ines Machado
    Valadao, Ivone
    Gomes, Eva
    Marinho, Antonio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1365 - 1366
  • [5] Successful Treatment of Refractory Prurigo Nodularis with Alitretinoin and Methotrexate Combination Therapy
    Yun, Dea Kwan
    Yeom, Kyujin
    Shon, Uri
    Park, Byung Cheol
    Choi, Mi Soo
    Kim, Myung Hwa
    ANNALS OF DERMATOLOGY, 2023, 35 : S388 - S389
  • [6] Successful treatment of prurigo nodularis with cyclosporin A
    Hershko, K
    Ingber, A
    JOURNAL OF DERMATOLOGICAL TREATMENT, 1999, 10 (01) : 63 - 65
  • [7] Treatment of Refractory Prurigo Nodularis With Lenalidomide
    Kanavy, Holly
    Bahner, Jennifer
    Korman, Neil J.
    ARCHIVES OF DERMATOLOGY, 2012, 148 (07) : 794 - 796
  • [8] Dupilumab for treatment-refractory prurigo nodularis
    Kovacs, Balint
    Rose, Ellen
    Kuznik, Nadine
    Shimanovich, Iakov
    Zillikens, Detlef
    Ludwig, Ralf J.
    Thaci, Diamant
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (06):
  • [9] Abrocitinib as a novel therapeutic approach for refractory prurigo nodularis: real-world evidence
    Demirbas, Abullah
    Diremsizoglu, Esin
    Cinar, Gizem
    Vural, Cigdem
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [10] Correction to: Abrocitinib as a novel therapeutic approach for refractory prurigo nodularis: real world evidence
    Abdullah Demirbas
    Esin Diremsizoglu
    Gizem Cınar
    Cigdem Vural
    Archives of Dermatological Research, 317 (1)
12345